跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,785 条关于
“Hepatitis delta virus”
全部
13,785
临床试验
9,797
药物
1,497
机构
71
资讯
2,420
去年
Vir Biotechnology's CHD Treatment Receives FDA Breakthrough Therapy and EMA PRIME Designations
去年
Vir Biotechnology's SOLSTICE Trial Shows Promise in Hepatitis Delta Virus Treatment
去年
Vir Biotechnology Receives Positive EU Opinion for Orphan Drug Designation of Tobevibart and Elebsiran in Chronic Hepatitis Delta
去年
Vir Biotechnology Receives Positive EU Opinion for Orphan Drug Designation of Tobevibart and Elebsiran in Chronic Hepatitis Delta
去年
FDA Grants Breakthrough Therapy Status to Novel Hepatitis Delta Treatment Brelovitug
7年前
Vir Biotechnology's Tobevibart and Elebsiran Receive FDA and EMA Designations for Chronic Hepatitis Delta Treatment
去年
Vir Biotechnology's Hepatitis Delta Treatments Receive Orphan Drug Status from EMA
11个月前
Vir Biotechnology to Present 48-Week SOLSTICE Trial Results for Hepatitis Delta Combination Therapy at AASLD 2025
去年
EMA Supports Orphan Drug Designation for Vir's HDV Therapy
去年
Vir Biotechnology Receives Positive EU Opinion for Hepatitis Delta Therapy
第 1 页,共 242 页
上一页
下一页